StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.53−0.01 (-1.40%)

Close on Nov 16, 2026Market cap $14.48MP/E –Yield –

Citius Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Citius Pharmaceuticals's total debt was $306.41M at Jun 30, 2026. For fiscal 2025 it was $300.00M, up 182178.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Sep 30, 2025$300.00M+182178.9%
FY2020Sep 30, 2020$164.58K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$306.41M+2.1%
Q2 FY2026CQ1 2026Mar 31, 2026$300.00M0.0%
Q1 FY2026CQ4 2025Dec 31, 2025$300.00M0.0%
Q4 FY2025CQ3 2025Sep 30, 2025$300.00M+182178.9%
Q3 FY2025CQ2 2025Jun 30, 2025$300.00M+182178.9%
Q2 FY2025CQ1 2025Mar 31, 2025$300.00M+182178.9%
Q1 FY2025CQ4 2024Dec 31, 2024$300.00M+182178.9%
Q2 FY2021CQ1 2021Mar 31, 2021$164.58K–
Q1 FY2021CQ4 2020Dec 31, 2020$164.58K–
Q4 FY2020CQ3 2020Sep 30, 2020$164.58K–
Q3 FY2020CQ2 2020Jun 30, 2020$164.58K–

More Citius Pharmaceuticals figures

See a number that looks wrong?